Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease.
Sign Up to like & getrecommendations! Published in 2019 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izz250
Abstract: OBJECTIVES Early discontinuation of infliximab (IFX) in pregnant women with inflammatory bowel disease (IBD) decreases the intrauterine fetal exposure to the drug but may increase the risk of disease flaring leading to poor pregnancy outcomes.… read more here.
Keywords: inflammatory bowel; discontinuation infliximab; disease; early discontinuation ... See more keywords